The FDA informed consent regulations require the consent document to include a description of any additional costs to the subject that may result from participation in the research. IRBs should ensure that the informed consent documents outline any additional costs that will be billed to study subjects or their insurance company as a result of participation in the study. IRBs should also ensure that any such charges are appropriate and equitable.

‍